StartUp Health July 21, 2021

More than $740M in health innovation funding was reported this week, including rounds for two StartUp Health portfolio companies: Quit Genius and avoMD.

Quit Genius, a London, UK- and New York, NY-based startup on a mission to end addictive behaviors through digital therapeutics, raised a $64M Series B co-led by Kinnevik and Atomico, with participation from Triple Point Ventures, Octopus Ventures and StartUp Health. source>

avoMD, a New York, NY-based startup on a mission to increase the adoption of evidence-based medicine and other critical information at the point of care, raised $3M from Dunamu, Mirae Asset Global Investments, SpringCamp, FuturePlay, and World Trade Ventures. source>

Other recent deals included:

TMRW Life Sciences, a New York, NY-based life sciences technology company...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Technology, Trends
Funding Flows to Value-Based Care, Defib Tech, Analytics, and More | StartUp Health Insights: Week of Apr 23, 2024
Evidence On Private Equity Suggests That Containing Costs And Improving Outcomes May Go Hand-In-Hand
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
Avive scores $57M for portable cardiac arrest device

Share This Article